Putrefactive SCFAs

Putrefactive short-chain fatty acids (SCFAs) are metabolites produced by the bacterial fermentation of proteins and amino acids in the gut. Key putrefactive SCFAs include isobutyric acid, isovaleric acid, and valeric acid.

Their levels reflect both the composition and metabolic activity of the gut microbiome—particularly the protein-fermenting, putrefactive bacteria—and have been linked to various gastrointestinal, metabolic, and neurological conditions.

The fermentation of undigested protein by gut microbiota can lead to the production of other putrefactive metabolites (e.g., ammonia, hydrogen sulfides, phenols, indoles) which can contribute to gut dysbiosis and increase the risk of gastrointestinal and other metabolic diseases

Production and Sources

Putrefactive SCFA production depends on the following:

Gut Microbiome

Bacteria such as Bacteroides, Clostridium, and Fusobacterium ferment proteins and amino acids to produce putrefactive SCFAs.

Dietary Protein

High-protein diets—especially those rich in red and processed meats—increase the substrate available for protein fermentation.

Intestinal Transit Time

Slower transit times allow more protein fermentation, leading to higher SCFA production; faster transit times limit this process.

Types of Putrefactive SCFAs

The following are the main types of putrefactive SCFAs: 

Isobutyric Acid

Derived from valine fermentation; associated with inflammatory bowel diseases (IBD) and colorectal cancer.

Isovaleric Acid

Produced primarily from leucine fermentation; elevated levels correlate with IBD and gastrointestinal dysbiosis.

Valeric Acid

Formed from proline and hydroxyproline fermentation. Valeric acid is associated with health benefits including reduced risk of eczema, neuroprotective effects in Parkinson's disease, and gut protection. 

Additionally, it acts as a potent histone deacetylase inhibitor, which may help support health in conditions linked to inflammation and disease pathologies.

Note: Other SCFAs (e.g., butyric acid and acetic acid) demonstrate beneficial effects on health; these SCFAs are produced from dietary fiber. 

Health Implications

Putrefactive SCFAs have been linked to the following conditions:

Inflammatory Bowel Diseases (IBD)

Elevated isobutyric and isovaleric acid levels have been linked to IBD, possibly through increased inflammation and impaired gut barrier function.

Colorectal Cancer Risk

High levels of some putrefactive SCFAs may be associated with tumorigenesis through oxidative stress and inflammatory mechanisms.

Metabolic Disorders: Is Valeric Acid Linked?

Valeric acid is a five-carbon fatty acid that is structurally similar to dimethylguanidino valeric acid (DMGV), but DMGV is not directly produced from valeric acid. Instead, DMGV is formed through the transamination of asymmetric dimethylarginine (ADMA) by the enzyme alanine glyoxylate aminotransferase 2 (AGXT2). 

Despite this difference in biosynthesis, DMGV shares a similar valeric acid backbone, which contributes to its name. DMGV has been associated with metabolic problems, particularly nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. 

However, it is important to note that while DMGV resembles valeric acid structurally, it is not a direct metabolite of valeric acid itself, so valeric acid cannot directly be said to negatively impact metabolic health.

Lab Testing for Putrefactive SCFAs

Common samples include stool. Proper collection and storage are critical to preserve SCFA integrity.

Follow the instructions from your test kit completely to reduce risk of improper collection. Ship immediately. 

Analytical Techniques

Gas chromatography coupled with mass spectrometry (GC-MS) is the standard method for accurate quantification.

Test Interpretation

Interpreting Putrefactive SCFAs includes consideration of the following:

Normal Reference Ranges

Baseline ranges are established based on the sample type and patient population. (Note: Reference ranges may vary between laboratories and should be interpreted in context.)

One lab company reports a “Products of Protein Breakdown” biomarker reference range, which includes the sum of isovaleric, isobuytric, and valeric acids as 1.8-9.9 micromol/g. 

Clinical Implications of Elevated Levels

High levels of putrefactive SCFAs may indicate:

• Dysbiosis or an overgrowth of putrefactive bacteria

• Increased intestinal inflammation

• Increased protein intake 

• Higher risk for IBD, colorectal cancer, or metabolic dysfunction

Clinical Implications of Decreased Levels

Low levels could suggest:

• A lower prevalence of protein fermentation in the gut, and/or low protein intake

• Possibly a predominance of carbohydrate-fermenting, beneficial bacteria

However, extremely low levels might also indicate malabsorption or other underlying conditions that warrant further evaluation

Related Biomarkers to Test

The following biomarkers may be considered in conjunction with putrefactive SCFAs:

Trimethylamine N-oxide (TMAO)

A metabolite that is linked to cardiovascular risk; its production is influenced by gut microbial composition.

Comprehensive Stool Analysis

A comprehensive stool analysis such as the GI MAP test or GI Effects test provides valuable insights into gut microbiota composition, digestive function, and microbial fermentation patterns, helping to identify dysbiosis and imbalances that may influence the production of putrefactive SCFAs like isobutyric and isovaleric acids.

Amino Acid Testing in Blood and Urine

This testing measures amino acid levels in plasma or urine to assess protein metabolism, detect nutrient imbalances, and support the understanding of metabolic shifts related to microbial fermentation, including the production of specific SCFAs linked to protein breakdown.

Dietary and Lifestyle Factors

Diet and lifestyle are cornerstones of gut health. 

Diet

A protein-rich diet (especially from animal sources) can elevate putrefactive SCFAs. Balancing protein with dietary fiber may help shift fermentation toward beneficial SCFAs.

Fiber Intake

High-fiber diets promote the growth of carbohydrate-fermenting bacteria, potentially mitigating the production of putrefactive SCFAs.

Probiotics and Prebiotics

Support a healthy gut microbiome, which can help regulate SCFA production.

Exercise and Stress Management

Regular physical activity and stress reduction can positively influence gut health and microbiome balance.

Order Putrefactive SCFAs Testing

Click here to order testing that includes Putrefactive SCFAs.